iRhythm
Update in progressIRTC (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
iRhythm Holdings, Inc. is a digital health company that designs and commercializes device-based ambulatory cardiac monitoring to diagnose arrhythmias in the United States. Its Zio services include long- and short-term monitoring and mobile telemetry. It offers the Zio Monitor, Zio XT, and Zio AT systems, plus Zio ECG Utilization Software. Zio AT supports 14-day wear with a patch and gateway. Headquarters in San Francisco; renamed in 2026 from iRhythm Technologies, Inc.
Company score
- Sentiment
- -0.23
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.49
- Governance
- -0.80
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.32
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.27
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Quentin S. Blackford
- Founded2006
- Employees2,400
- Websitewww.irhythmtech.com
Identifiers
- ISINUS4500561067
- FIGIBBG001J19V24
- LEI549300FJI72RJGDQS384
- CUSIP450056106
- CIK0001388658